Frontiers in Cancer Chemistry Research

Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches

Research Articles

Breaking the Shield: How Novel CDK12 Inhibitors Are Revolutionizing Triple-Negative Breast Cancer Treatment

Explore how covalent CDK12 inhibitors are creating breakthroughs in triple-negative breast cancer treatment by targeting DNA repair mechanisms and inducing BRCAness.

Eli Rivera
Oct 09, 2025

Popular Articles